Poland Cancer Pain Management Market Analysis Report 2022 to 2030

Poland Cancer Pain Management Market Analysis

$ 3999

Poland's Cancer Pain Management market is projected to grow from $37.82 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be a rise in cancer cases, improvement in healthcare infrastructure, government initiatives, and advances in pain management technologies. The market is segmented by drug type and by disease. Some of the major players include Hasco-Lek, Mundipharma, Pfizer, Teva Pharmaceuticals, Abbott, and Sanofi.

ID: IN10PLHS002 CATEGORY: Healthcare Services GEOGRAPHY: Poland AUTHOR: Neha Davda

Buy Now

Poland Cancer Pain Management Market Executive Summary

Poland's Cancer Pain Management market is projected to grow from $37.82 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. Poland's national healthcare spending as a share of GDP in 2019 was 6.45% or $1,014 per person. In the past ten years, Poland has regularly spent less on health than the average EU nation, both in terms of per-capita spending and as a proportion of GDP.

The majority of chronic pain is because of the illness, whereas the majority of acute pain is brought on by therapy or diagnostic procedures. Uncomfortable side effects from chemotherapy and radiotherapy may persist for a long time following the course of treatment. The location and stage of the tumor have the most effects on whether or not there is discomfort. Patients with cancer have pain constantly, and two-thirds of those with advanced illness experience it to the point that it interferes with their sleep, emotions, social interactions, and daily activities. Europe is a well-known player in the global market for cancer pain treatment, and it is also the location of some of the top pharmaceutical companies that are actively involved in the development of brand-new opioids.

Market Dynamics

Market Growth Drivers

The cancer pain management market in Poland is expected to be driven by factors such as a rise in cancer cases, improvement in healthcare infrastructure, and advances in pain management technologies. Moreover, the Polish government has shown a dedication to improving citizens' access to healthcare by supporting the growth of the healthcare industry. This assistance has contributed to the development of a favorable environment for the cancer pain management market.

Market Restraints

In Poland, there is limited availability of pain management drugs available despite the rising need for cancer pain relief treatments. Patients may find it challenging to get the therapies they require, which could hinder the market's growth.

Competitive Landscape

Key Players

Hasco-Lek (POL)
Mundipharma
Pfizer
Teva Pharmaceuticals
Abbott
Sanofi

Healthcare Policies and Regulatory Landscape

The National Health Fund and the Ministry of Health in Poland are in charge of establishing the regulatory framework and healthcare policies for the market for cancer pain treatment. The nation's residents have access to cancer pain management therapies through its public healthcare system. Government funding supports the system, and healthcare professionals are expected to follow national standards and recommendations for cancer pain management. The Ministry of Health establishes criteria for the delivery of pain management services, including the use of pain medication, and offers recommendations for its application. For qualifying patients, the National Health Fund covers the cost of several cancer pain management therapies, including medications.

Reimbursement Scenario

The National Health Fund (NFZ) oversees the reimbursement situation for the market for cancer pain management in Poland. For qualifying patients, the NFZ pays the cost of several cancer pain management therapies, including medications. Patients can get these therapies through healthcare professionals who are a part of the public healthcare system, and the reimbursement procedure is typically simple. The NFZ accepts applications for reimbursement from patients who need treatment for cancer pain management. The NFZ will assess the request and decide if the therapy is eligible for payment once individuals submit relevant medical documents, including a prescription for the treatment. Depending on the particular treatment and the patient's conditions, the reimbursement amount may change. The patient could occasionally be asked to cover a co-pay or a percentage of the cost of the therapy.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cancer Pain Management Market Segmentation

By Drug Type (Revenue, USD Billion):

Non-steroidal anti-inflammatory medicines relieve pain at the site of injury by blocking the cyclooxygenase enzyme, which prevents prostaglandin formation. NSAIDs are a class of medications that includes medications with analgesic, antipyretic, and, at higher doses, anti-inflammatory properties.

Opioids
Morphine
- Fentanyl
- Others
Non-Opioids
Acetaminophen
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Nerve Blockers

By Disease Indication (Revenue, USD Billion):

Based on disease Indication the market is segmented into:

Lung Cancer
Colorectal cancer
Breast cancer
Prostate cancer
Blood cancer
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.